These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 27180667)
1. [Cholesterol metabolism in patients with type 2 diabetes]. Vrablík M; Tůmová E Vnitr Lek; 2016 Mar; 62(3):189-94. PubMed ID: 27180667 [TBL] [Abstract][Full Text] [Related]
2. Lipids and lipid management in diabetes. Jaiswal M; Schinske A; Pop-Busui R Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):325-38. PubMed ID: 24840262 [TBL] [Abstract][Full Text] [Related]
3. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes. Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404 [TBL] [Abstract][Full Text] [Related]
6. The Atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in Diabetes. Stahel P; Xiao C; Hegele RA; Lewis GF Can J Cardiol; 2018 May; 34(5):595-604. PubMed ID: 29459241 [TBL] [Abstract][Full Text] [Related]
7. [Consensus document on the treatment of dyslipidemia in diabetes]. Hormigo-Pozo A; Mancera-Romero J; Perez-Unanua MP; Alonso-Fernandez M; Lopez-Simarro F; Mediavilla-Bravo JJ; Semergen; 2015 Mar; 41(2):89-98. PubMed ID: 25533449 [TBL] [Abstract][Full Text] [Related]
8. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
9. [Diabetic dyslipoproteinemia: beyond LDL]. Merkel M Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932 [TBL] [Abstract][Full Text] [Related]
10. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus. Udawat H; Goyal RK Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472 [TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge]. Pedro-Botet J; Chillarón JJ; Benaiges D; Flores-Le Roux JA Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375 [TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat? Halcox J; Misra A Metab Syndr Relat Disord; 2015 Feb; 13(1):1-21. PubMed ID: 25402738 [TBL] [Abstract][Full Text] [Related]
13. [Diabetes and dyslipidemia: Why are they so closely related?]. Rašlová K Vnitr Lek; 2016; 62(11):908-911. PubMed ID: 28128578 [TBL] [Abstract][Full Text] [Related]
15. Combination lipid therapy in type 2 diabetes mellitus. Vergès B Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502 [TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention. Steinmetz A Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835 [TBL] [Abstract][Full Text] [Related]
17. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian]. Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165 [TBL] [Abstract][Full Text] [Related]
18. [Effect of smoking on diabetes mellitus and dyslipidemia (effect of smoking on glucose and lipid metabolism)]. Saito K; Sone H Nihon Rinsho; 2013 Mar; 71(3):443-8. PubMed ID: 23631232 [TBL] [Abstract][Full Text] [Related]
19. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events. Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M; Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618 [TBL] [Abstract][Full Text] [Related]